These combined observations suggest that inherited variations in the TP53 gene (polymorphisms) between AA and CA Americans contribute to the differences discussed above in the incidence of MGUS and SMM, and that spontaneous TP53 mutations may differentially occur on distinct TP53 haplotypes, conferring new phenotypes to MM among these populations. This evidence concerns the gene TP53 and Miyoshi myopathy.